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© 2011 The Japan Society of Histochemistry and S100 proteins comprise a large family of Ca2+-binding proteins and exhibit a variety of intra-
and extracellular functions. Despite our growing knowledge about the biology of S100 proteins
in some tissues such as brain and smooth muscle, little is known about S100 proteins in
the normal mammalian reproductive tissue. In the present study, we investigated the
distribution pattern of S100A6 (alternatively named calcyclin) in the murine ovary by
immunohistochemical study using specific antibody. S100A6 was localized substantially in
the cytoplasm of luteal cells, with concomitant expression of S100A11, another S100 protein,
but not in the other type of cells such as oocytes, follicle epithelial cells (granulosa cells),
and cells of stroma including theca interna cells in the murine ovary. S100A6-immunoreactive
corpora lutea (CLs) were divided into two types: homogeneously and heterogeneously stained
CLs, and possibly they may represent differentiating and mature CL, respectively. Our
regression analysis revealed that expression level of S100A6 positively correlated with that
of cytochrome P450 11A, a steroidogenic enzyme in the heterogeously stained CL. These
results suggested that S100A6 may contribute to differentiation of steroidogenic activity of
luteal cells in a synergistic manner with S100A11 by facilitating some shared functions.
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I. Introduction
S100 proteins constitute a large family of small (10–
14 kDa) Ca2+-binding proteins characterized by two EF-
hands as Ca2+-binding sites, and exhibit a variety of
functions, including cell growth and differentiation, cyto-
skeletal dynamics, and Ca2+ homeostasis (for a review see
[12]). Originally, S100α and S100β were isolated in the
bovine brain [28] and in the past decade, approximately
twenty S100 genes have been identified in a variety of
species, including humans and mice [23]. S100 proteins
exist as homo or hetero dimers in solution, and upon Ca2+-
binding, they undergo a large conformational change, which
enables these proteins to interact with various target proteins.
Through these interactions, S100 proteins transduce envi-
ronmental signals for intracellular activities such as cAMP
mediated-signaling and vesicular transportation/exocytosis
(for a review see [7]). In addition, some S100 proteins (e.g.
S100B and S100A12) are secreted from cells, and bind to
cell-surface receptors such as the receptor of advanced
glycation endproducts (RAGE), and produce extracellular
effects on neurons and inflammatory cells [3, 10, 31]. S100
proteins have also attracted much interest owing to their
close association with a number of human diseases, including
cancer, chronic inflammation, neurodegenerative disorders
and cardiomyopathies, which suggests the potency of S100
proteins as diagnostic marker and therapeutic drug targets,
although the precise mechanisms by which S100 proteins
participate in disease occurrence remain largely unknown
(for a review see [13]). Several lines of evidence have
demonstrated S100 protein-like immunoreactivity [26, 29]
and S100-gene expression by microarray analysis in the
ovarian tumor [6, 14, 18]. However, little is known about
the subtype-specific immunological distribution pattern of
S100 proteins, particularly in the normal reproductive tissue,
with the exceptions of S100A10 and S100A11 [11].Hanaue et al. 10
Therefore, immunohistochemical analysis of S100 proteins
other than S100A10 and S100A11 in the normal reproductive
tissue is certainly essential for understanding the biology of
S100 proteins.
S100A6 (formerly named calcyclin) was first identified
as a gene, the expression level of which increased when
quiescent cells were stimulated to proliferate [15]. Its
involvement in the process of cell cycle has been validated
by several lines of evidence demonstrating reduced prolif-
erative activities in S100A6 gene-deficient cells [4, 16, 20,
30]. S100A6 interacts with many targets, including Siah-
1-interacting protein (SIP), glyceraldehydes-3-phosphatase
dehydrogenase (GAPDH) and several annexins (for a review
see [21]). S100A6 expression is elevated in a number of
malignant tumors, such as acute myeloid leukemia, neuro-
blastoma and melanoma cell lines [5, 35]; therefore S100A6
may be a useful diagnostic marker for defining cancer
stage. However, the precise molecular mechanism by which
S100A6 regulates tumorigenesis remains unknown.
In the present study, we investigated the distribution
of S100A6 in the normal murine ovary and found that
S100A6 is expressed prominently in the luteal cells of the
CL and that S100A6 expression positively correlated with
the expression of a steroidogenic enzyme. In addition,
S100A6 was also colocalized with S100A11, another S100
protein, in the luteal cells, which implies that two S100
proteins have some combined effect on the steroidogenic
activity of luteal cells.
II. Materials and Methods
Animals
ICR female mice (10–12 weeks old) were obtained
from the CLEA Japan (Tokyo, Japan). All mouse experi-
ments were approved of and performed in accordance with
the guidelines of the Animal Care Committee of Toho
University.
Cloning and bacterial expression of mouse S100A6
Total RNA was isolated from the mouse ovary using
RNA Bee (AMS Biotech., Abingdon, UK). RT-PCR was
performed with ~5 μg of cDNA templates reverse-
transcribed from the mouse ovary RNA. Oligonucleotide
PCR primers were synthesized on the basis of the corre-
sponding N- and C-terminal sequences of mouse S100A6
(5'-CATATGCATGCCCTCTGG-3' and 5'-CGGATCCTTA
TTTCAGAGCT-3' for N- and C-termini respectively). The
initiation and stop codons are underlined. Amplification
was performed as follows: 10 sec at 98°C, 15 sec at 61°C,
and 90 sec at 68°C for 35 cycles. PCR products were
subcloned into pGEM-T (Promega, Madison, WI), and found
to be identical to the coding regions of S100A6 protein. The
NdeI- and SpeI-digested fragment was excised and ligated
with pET3a (Novagen, EMD, Darmstadt, Germany). For
protein expression, the recombinant plasmid was introduced
into Escherichia coli BL21 pLysS (Novagen). After induc-
tion of expression by IPTG, recombinant S100A6 was
purified according to the method for the purification of
frog S100-like calcium binding protein described previously
[27].
Western blot analysis of S100 proteins
Known amounts (50, 150 and 300 pmoles) of recom-
binant S100 proteins (S100A6 and S100A11) were electro-
phoresed in 15–20% precast gradient gel (WAKO, Osaka,
Japan) and transferred onto a PVDF membrane (Immobilon
P; Millipore, Bedford, MA). After blocking, blots were
probed with the primary antibodies (sheep polyclonal anti-
S100A6 antibody, 1:100, R&D systems, Mineapolis, MN;
sheep polyclonal anti-S100A11 antibody, 1:100, Randox
Life Science, Crumlin, UK). After washing, blots were
reacted with HRP-conjugated secondary antibody (MP
Biomedicals, Aurora, OH), and immunoreactive proteins
were acquired using LAS-1000 (Fuji Film, Tokyo, Japan).
Immunohistochemistry
Ovaries were dissected from mice with normal estrous
cycle, and fixed in 10% formalin, dehydrated with alcohol,
embedded in paraffin, and cut at ~5 μm thickness. After
blocking, the specimens were subjected to a standard
immunohistochemical procedure using commercially avail-
able antibodies (sheep or rat polyclonal anti-S100A6
antibody, 1:100; sheep polyclonal anti-S100A11 antibody,
1:100; rabbit polyclonal anti-cytochrome P450 11A
(CYP11A) antibody, 1:100, ProteinTech, Chicago, IL). After
rinse, the specimens were treated with secondary antibodies
(Alexa Fluor 594 and Alexa Fluor 488; 1:1000, Molecular
Probes, Invitrogen, Carlsbad, CA) and nuclei-stained by
DAPI (1 μg/ml; Dojindo, Kumamoto, Japan). Negative
controls were performed by substituting the primary anti-
body with a non-immune normal IgG from the same sources
at the same concentration. Stained specimens were observed
using either a conventional fluorescence microscope
(Olympus, Tokyo, Japan) or an inverted confocal laser
microscope (LSM510; Carl Zeiss, Oberkochen, Germany)
with an appropriate set of excitation and emission filters.
Quantitative evaluation
For quantitative analyses with a confocal microscope,
the aperture, detector gain, and offset were kept constant
during a series of observations, and signal intensity was set
within a linear range (8 bit scale, 0–255). Images were
captured at the optical slice of <0.6 μm, and quantified
areas (10 μm2 each, 180 pixels) were randomly chosen. To
quantitatively evaluate the colocalization of S100A6 with
CYP11A, the mean intensity of the cytoplasm of luteal cells
within the defined area (10 μm2 each) was quantified by
using a software attached to the confocal laser microscope,
and subtracted by the mean intensity in follicle cell as a
background control, followed by the regression analysis as
described elsewhere [1, 24]. Statistical significance was
tested by analysis of variance (ANOVA). All quantifications
were performed with lab personnel blinded to the conditions.S100A6 in the Murine Ovary 11
III. Results and Discussion
Specificity of antibodies
In general, amino acid-sequence homologies of mouse
S100 proteins are not necessarily high, and occur within a
range of 10–56% homology. In particular, sequence homol-
ogy between S100A6 and S100A11 is substantially low
(~20%). Since questions may be raised as to the antibody-
specificity among subtypes of one large protein family, we
cloned mouse S100A6 from the murine ovary cDNA and
examined the specificity of antibodies by Western analysis
using recombinant S100A6 and recombinant S100A11,
another S100 protein that was subsequently focused on
in this study. Anti-S100A6 antibody exhibited immuno-
reactivity against recombinant S100A6 but showed no cross-
reaction even against excessive amount of S100A11 (6-fold
quantity of S100A6) (Fig. 1A). Meanwhile, anti-S100A11
antibody reacted with recombinant S100A11, but not with
the excessive amounts of S100A6 (Fig. 1B). These results
essentially confirmed the specificity of the two antibodies.
Localization of S100A6 in the murine ovary
We examined the distribution pattern of S100A6 in the
murine ovary by immunohistochemistry using the specific
antibody described above. The result showed that S100A6
is localized substantially in the corpus luteum (CL in Fig. 2A,
Left) but not in the follicle (F in Fig. 2A). Interestingly,
S100A6+ CLs showed a varied staining appearance: all
luteal cells were immunopositive in some CLs (Fig. 2A, CL
demarcated by a broken line), whereas a limited number of
luteal cells was immunopositive in other CLs (Fig. 2A, CL
demarcated by a solid line). Furthermore, although S100A6
was present in the cytoplasm of luteal cells in both types of
CLs (Fig. 2B), the intensity of S100A6-staining displayed
considerable variation between the two types of CLs. The
staining intensity was comparatively homogeneous in the
former type of CL (referred to as homo CL), whereas it was
heterogeneous in the latter type of CLs (referred to as hetero
CL) (see Fig. 2B, Left; intense signal (arrow) and weak one
(arrowhead)). This heterogeneous staining pattern implies
that the S100A6 expression level may represent meaningful
differences  in  the  maturation  process  of  luteal  cells.  In-
cidentally, in the hetero CL, we observed much autofluo-
rescence (asterisk; Fig. 2B, Left), possibly due to residual
red blood cells, which suggested that the hetero CL was
well vasculated and therefore represented differentiating CL
at the early luteal stage [2]. Meanwhile, the homo CLs
contained sinusoidal-like structure (arrowheads; Fig. 2B,
Right), suggesting that these CLs were matured CLs at the
mid luteal stage [2]. It should be noted that the existence
of two CLs at different developmental stages in the identical
ovary is due to the short estrous cycle in mice, which is
consistent with another report [34].
Colocalization of S100A6 with a steroidogenic enzyme in the 
luteal cells
Several steroidogenic enzymes have been reported
to alter their amounts during the developmental stages of
the mammalian CL. For example, cytochrome P450 11A
(CYP11A), a first and rate-limiting enzyme that cleaves the
side chain of cholesterol producing pregnenolon, increases
in the number of immunopositive cells as the CL differen-
tiates [33]. To characterize the nature of S100A6+ luteal
cells, we examined the colocalization of S100A6 with
CYP11A. The result showed that S100A6 colocalized with
CYP11A both in the hetero (Fig. 3A) and homo CLs (not
shown). To investigate the potential correlation between
expression levels of S100A6 and CYP11A, we quantified
the mean intensity of S100A6- and CYP11A-immunoposi-
tive cytosolic regions within a small defined area (10 μm2)
in the hetero CLs, and performed regression analysis. The
result clearly demonstrated a positive correlation between
the expression levels of these two proteins (Fig. 3B; n=100,
three mice, F(1,32)=30, p<0.01, ANOVA): S100A6 expres-
sion level was increased in parallel with CYP11A expression
level, which suggested that S100A6 expression may be
involved in an increase in the steroidogenic activity of luteal
cells. CYP gene expression has been shown to be regulated
by ubiquitous transcription factors such as AP-1 and SP-1,
but more efficiently by ovary-specific transcription factors
such as steroidogenic factor-1 (SF-1) and LRH-1 [8, 22].
Our computational analysis to estimate the transcription
binding site in the S100A6 gene surely found both the AP-
1 and SP-1 sites but unfortunately failed to detect the
sites for SF-1 or LRH-1 (not shown), suggesting that the
transcriptional regulation of S100A6 gene may be different
from that of CYP11A.
Colocalization of S100A6 with S100A11 in luteal cells
Since we recently discovered that S100A11, another
Fig. 1. Specificity of antibodies. (A) Specificity of
anti-S100A6 antibody. Top: Coomassie Brilliant
Blue (CBB)-stained pattern of recombinant S100A6
(50 pmoles), and recombinant S100A11 (50, 150
and 300 pmoles), Bottom: treated with anti-S100A6
antibody. (B) Specificity of anti-S100A11 antibody.
Top: CBB-stained pattern of recombinant S100A11
(50 pmoles), and recombinant S100A6 (50, 150 and
300 pmoles), Bottom: treated with anti-S100A11
antibody.Hanaue et al. 12
S100 protein, was localized in the cytoplasm in the luteal
cells [11] similarly as seen for S100A6 in our current study,
we next examined colocalization of these two S100 proteins.
The result revealed that S100A6 and S100A11 colocalized
in luteal cells in the hetero CL (Fig. 4), which indicated that
these two proteins are concomitantly expressed in the luteal
cells during luteal cell development. CL is formed via diverse
cellular events involving the attenuation of cell proliferation
and subsequent cell differentiation. The cyclin-dependent
kinase (Cdk) inhibitor p21, the expression level of which is
inhibited by β-catenin signaling, has been shown to cause
cell cycle arrest, thereby initiating differentiation of luteal
cells [17, 19]. S100A6 has been shown to interact with SIP,
a Siah-1-interacting protein, which facilitates β-catenin
degradation via ubiquitinylation in HEK293 cells, leading
to p21 liberation [9, 25]. Interestingly, S100A11 has been
shown to be phosphorylated in response to either exposure
of high extracellular Ca2+ or TGFβ, which leads to p21
expression, induces growth inhibition of human keratino-
cytes. Thus, S100A6 and S100A11 may interact with indi-
vidual targets, activating separate signaling pathways, and
ultimately have a synergistic effect on the differentiation of
luteal cells by enhancing p21 function. Furthermore, it is
worth noting that the differentiation of luteal cells initially
occurs at the stage of granulosa cells in the preovulatory
follicle, following termination of the cell division by the
LH surge (for a review see [32]). Our immunohistochemical
studies thus far have revealed no significant immuno-
reactivity against S100A6 (Fig. 2A) or S100A11 [11] in
granulosa cells in the preovulatory follicle, suggesting that
S100A6 and S100A11 may be involved with the differen-
tiation of luteal cells, particularly after ovulation in the CL.
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Fig. 2. Localization of S100A6 in the murine ovary. (A) Representative images of the murine ovary treated with anti-S100A6 antibody (Left) or
normal sheep IgG as negative control (Right). Anti-S100A6, S100A6-immunoreactivities are prominently seen in the corpora lutea (CLs), but
not in the follicle (F). Two types of staining pattern of CLs; homogeneously stained CL (broken line) and heterogeneously stained CL (solid
line) are indicated. Bar=100 μm. Normal antibody, no specific immunoreactivity was detected. Inset, bright field image of the ovary. Bar=100
μm. (B) Higher-magnification images of S100A6-immunopositive luteal cells. Hetero CL, representative image of heterogeneously stained CL.
S100A6 is localized prominently in the cytosol of corpus luteal cells, and immunoreactive signals are intense in some S100A6+ luteal cells
(arrow) and weak in other cell (arrowhead). Asterisk denotes autofluorescence signal. Bar=20 μm. Homo CL: representative image of homo-
geneously stained CL. Immunoreactive signals are comparatively homogeneous. Bar=20 μm. Insets, representative images of S100A6-
immunopositive luteal cells in homo and hetero CLs, respectively. Bar=5 μm.S100A6 in the Murine Ovary 13
Fig. 3. Colocalization of S100A6 with cytochrome P450 11A in the luteal cells. (A) Representative confocal images of the luteal cells treated
with anti-S100A6 and anti-cytochrome P450 11A (CYP11A) antibodies. S100A6/DAPI, confocal image of S100A6+ luteal cells (red). Nuclei
were stained with DAPI (blue). CYP11A/DAPI, confocal image of CYP11A+ luteal cell (green) in the identical section. Merged, merged
image. Bar=20 μm. (B) Regression analysis of S100A6 and CYP11A immunoreactive intensitites. Immunoreactive intensities in the cytosol of
luteal cells were quantified (squares in (A), 10 μm2 per square, arrows) and subtracted by the mean intensity in the follicle. Resultant values
were analyzed (n=100; three mice; a.u., optical arbitary units). Expression levels of two proteins correlates positively (F(1,32)=30, p<0.01,
ANOVA).
Fig. 4. Colocalization of S100A6 with S100A11 in the luteal cells. Representative confocal images of the luteal cells treated with anti-S100A6,
and anti-S100A11 antibodies. S100A6/DAPI, confocal image of S100A6+ luteal cells (red). Nuclei were stained with DAPI (blue). S100A11/
DAPI, confocal image of S100A11+ luteal cell (green) in the identical section. Merged, merged image. S100A6 and S100A11 colocalized with
each other. Bar=20 μm.Hanaue et al. 14
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